Questions, Feedback & Help
Send us an email and we'll get back to you ASAP. Or you can read our Frequently Asked Questions.
  • page settings
  • hide sidebar
  • show empty fields
  • layout
  • (too narrow)
  • open all
  • close all
Resources » Paper

von Samson-Himmelstjerna G et al. (2000) Parasitol Res "In vivo activities of the new anthelmintic depsipeptide PF 1022A."

  • History

  • Referenced

  • Tree Display

  • My Favorites

  • My Library

  • Comments on von Samson-Himmelstjerna G et al. (2000) Parasitol Res "In vivo activities of the new anthelmintic depsipeptide PF 1022A." (0)

  • Overview

    PMID:
    10726989
    DOI:
    10.1007/s004360050031
    Status:
    Publication type:
    Journal_article
    WormBase ID:
    WBPaper00054653

    von Samson-Himmelstjerna G, Harder A, Schnieder T, Kalbe J, & Mencke N (2000). In vivo activities of the new anthelmintic depsipeptide PF 1022A. Parasitol Res, 86, 194-9. doi:10.1007/s004360050031

    PF 1022A is a member of a new class of cyclic depsipeptides with antiparasitic activity. Following in vitro and laboratory animal studies it was tested for its anthelmintic efficacy in companion and livestock animals against a wide spectrum of intestinal nematodes and lungworms. Studies were carried out in rats, dogs, horses, sheep, and cattle. Animals were either naturally or experimentally infested. The efficacy of PF 1022A was investigated against the following parasite species: Strongyloides ratti and Nippostrongylus brasiliensis in rats, Ancylostoma caninum in dogs, small strongyles (cyathostomes) in horses, Trichostrongylus colubriformis and Haemonchus contortus in sheep, and Dictyocaulus viviparus in cattle. Doses varied from 1 to 10 mg/kg body weight for oral, subcutaneous or intravenous application in companion and livestock animals. High degrees of efficacy were found in all the above-cited examinations, and no clinical signs of intolerability were observed.


    Tip: Seeing your name marked red? Please help us identify you.